Log in to save to my catalogue

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-ne...

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-ne...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e12df5d86484ac796ec0eb06330249b

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer

About this item

Full title

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-05, Vol.11 (1), p.10510-10, Article 10510

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Survival of breast cancer patients has improved, and treatment-related changes regarding metabolic profile deterioration after neoadjuvant systemic treatment (NST) become important issues in cancer survivors. We sought to compare metabolic profile changes and the neutrophil-to-lymphocyte ratio (NLR) between patients undergoing neoadjuvant chemother...

Alternative Titles

Full title

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2e12df5d86484ac796ec0eb06330249b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e12df5d86484ac796ec0eb06330249b

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-89651-0

How to access this item